arBtrage CAPITALIZING MARKETS checking… Sign in

C4 Therapeutics, Inc.

CCCC Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$3.85
▼ -7.7% Today
as of Jun 7, 06:55 ET
Last 30 days +40.00% Apr 28 → Jun 05
$2.41 $2.94 $3.47 $4.00 $4.53 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$4.15
High
$4.16
Low
$3.79
Volume
$2M
Avg Vol
$2M
Mkt Cap
$405M
P/E (TTM)
Beta
52w High
$4.60
52w Low
$1.36
Div Yield
Shares Out
$104M

Overview

52-week range
$1.36
$4.60
77% of range
Avg surprise (last 2)
+13.8%
Avg reaction (last 2)
+3.2%
50% positive
Latest IV / EM
188%
EM ±26.0% · $4 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.73$-0.60$-0.46$-0.33$-0.20 Actual $-0.73Actual $-0.55Actual $-0.41Actual $-0.26Actual $-0.35Actual $-0.37Est $-0.48Actual $-0.37Actual $-0.44Actual $-0.20Est $-0.21 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-32M$-20M$-8M$4M$16M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue May 12, 2026Mar/2026 $-0.20 $-0.21 +4.8% +46.0% 0.0% earnings
Tue Sep 30, 2025Sep 2025 $-0.44 financials
Mon Jun 30, 2025Jun 2025 $-0.37 financials
Wed May 7, 2025Mar/2025 $-0.37 $-0.48 +22.9% +6.4% earnings
Mon Sep 30, 2024Sep 2024 $-0.35 financials
Sun Jun 30, 2024Jun 2024 $-0.26 financials
Sun Mar 31, 2024Mar 2024 $-0.41 financials
Sat Sep 30, 2023Sep 2023 $-0.55 financials
Fri Jun 30, 2023Jun 2023 $-0.73 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue$6M$11M$6M$7M$15M$12M
Cost of revenue
Gross profit
Operating income$-28M$-34M$-29M$-29M$-28M$-21M
Net income$-25M$-32M$-26M$-26M$-25M$-18M
EPS (diluted)$-0.20$-0.44$-0.37$-0.37$-0.35$-0.26

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$61M$75M$59M$78M$51M$55M$60M$73M
Inventory
Total current assets$245M$258M$207M$225M$233M$258M$273M$276M
Total assets$329M$359M$265M$297M$320M$350M$376M$381M
Long-term debt
Total liabilities$95M$102M$111M$122M$124M$134M$133M$134M
Total equity$234M$257M$154M$174M$195M$216M$243M$247M

Implied volatility — last 90 days

182%185%187%190%192% Jun 07 — IV 188% · EM ±26.0%

Sector peers